AVTXAvalo Therapeutics, Inc.
$13.43-0.37% 1Y
$13.43
$12.7452 weeks$22.87
Is it safe?
Watch
2 to watch, 4 without dataCaution warranted: heavy debt (CCC) and big price swings.
Credit gradeCCCderived · Jun 30, 2026
Debt against weak or negative operating profit. A rule of thumb on leverage, not a credit rating.
Drawdown risk86% volderived · Oct 8, 2026
Large price swings, high volatility. Worst drawdown -100% · now 41% below its 52-week high.
Where this answer is blind. Altman sits structurally low for utilities and pipelines; Beneish runs high for fast growers, since sales growth alone lifts it; banks and REITs are excluded.
Can AVTX take a bad year?
The deepest fall in AVTX's price history on file is −100%; it is 41% below its high today.
−100%
Worst drawdown on file · −41% today
- Annualised volatility
- 86%
Annualised volatility · three times the market's own swing
Details›
- Cash and short-term investments
- $400M
- EBITDA, trailing twelve months
- −$91M
- Operating profit, trailing twelve months
- −$91M
- Annualised volatilitytwo years of daily moves
- 86%
- Worst drawdown on file
- −100%
- Below its 52-week high
- 41%
Balance sheet from SEC filings; drawdown and volatility from end-of-day closes; Altman Z from the filed statements.